INVESTIGADORES
POSADAS MARTINEZ Maria Lourdes
artículos
Título:
Statistical Process Control: A Quality Tool for a Venous Thromboembolic Disease Registry
Autor/es:
MARIA LOURDES POSADAS MARTINEZ; LILIANA P. ROJAS; FERNANDO VAZQUEZ; FERNAN GONZALEZ BERNALDO DE QUIROS; GABRIEL WAISMAN; DIEGO GIUNTA
Revista:
Journal of registry management
Editorial:
J Registry Manag
Referencias:
Lugar: J Registry Manag. 2016 Summer;43(2):82-6.; Año: 2016 vol. 43 p. 82 - 86
Resumen:
Registry Manag. 2016 Summer;43(2):82-6.Statistical Process Control: A Quality Tool for a Venous Thromboembolic Disease Registry.Posadas-Martinez ML, Rojas LP, Vazquez FJ, De Quiros FB, Waisman GD, Giunta DH.AbstractOBJECTIVE:We aim to describe Statistical Control Process as a quality tool for the Institutional Registry of Venous Thromboembolic Disease (IRTD), a registry developed in a community-care tertiary hospital in Buenos Aires, Argentina.METHODS:The IRTD is a prospective cohort. The process of data acquisition began with the creation of a computerized alert generated whenever physicians requested imaging or laboratory study to diagnose venous thromboembolism, which defined eligible patients. The process then followed a structured methodology for patient´s inclusion, evaluation, and posterior data entry. To control this process, process performance indicators were designed to be measured monthly. These included the number of eligible patients, the number of included patients, median time to patient´s evaluation, and percentage of patients lost to evaluation. Control charts were graphed for each indicator.RESULTS:The registry was evaluated in 93 months, where 25,757 patients were reported and 6,798 patients met inclusion criteria. The median time to evaluation was 20 hours (SD, 12) and 7.7% of the total was lost to evaluation. Each indicator presented trends over time, caused by structural changes and improvement cycles, and therefore the central limit suffered inflexions.CONCLUSION:Statistical process control through process performance indicators allowed us to control the performance of the registry over time to detect systematic problems. We postulate that this approach could be reproduced for other clinical registries.